NantKwest Inc.

(NK:NASDAQ

NantKwest is an innovative, clinical-stage immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and virally induced infectious diseases. NantKwest is the leading producer of clinical dose forms of off-the-shelf Natural Killer (NK) cell therapies.

streetwise book logo Streetwise Company Fact Sheet

2024/4/18 8:56:52

((NK:NASDAQ)